Alto Neuroscience, Inc. · NYSE:ANRO
BlackRock, Inc. reported a 6.00% stake in Alto Neuroscience, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.00% stake in Alto Neuroscience, Inc., 2,104,406 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 2,104,406
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.00% | 2,104,406 |
Source
Related
- Alto Neuroscience, Inc.
- BlackRock, Inc.
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026